Dear listmates, Joel Lubar, president of the ISNR, has, in a=20 letter to the membership, underscored that the=20 ISNR is focused on science, and there should be=20 no need for two separate organizations. As far as=20 I can see the ESNR/SAN and the ISNR agree on=20 focusing on science, but may want to acquire and=20 spread knowledge in different ways. A major issue, is the ability to make quick=20 decisions and allowing the SAN board and members=20 to develop their own solutions. An example could be that the ESNR/SAN held an=20 electronic ballot (smoothly implemented by=20 Patricia Bellinghausen) which cut costs radically=20 while saving a lot of time for everyone involved=20 (except for Patricia...). Another example: A future ESNR/SAN journal will=20 probably be electronic, saving distribution cost=20 and time. Hopefully it will be a FREE service=20 (after all scientific work in our field is mainly=20 financed by public institutions), thus making it=20 a valuable resource for researchers as well as=20 clinicians. Would the ISNR oppose a second=20 journal which is free? Very likely. I know I will subscribe to the JNT whether there=20 is a European neuroscience journal or not, and I=20 believe most members will. Will europeans still=20 turn up at the US ISNR and AAPB conferences? Of=20 course! Even though large membership numbers may seem=20 appealing, bigger isn=B4t always better. A small=20 organization here in Europe has a number of=20 benefits such as: - The ability to make decisions quickly. - Not having to communicate in the middle of the=20 night with boardmembers in the US. - Being outside the US don=B4t have to worry about american legal action. Light travel makes for a pleasant journey. I am sure the ESNR/SAN is grateful for the=20 economic start-up support from the ISNR, and I=20 believe that we are keeping the spirit of that=20 gift by promoting this exciting field. Having=20 separate organizations doesn=B4t mean splitting the=20 field. On the contrary, I think different=20 approaches will complement each other. I am excited about the new developments from SAN=20 which will benefit clinicians and scientists,=20 with member-driven activity, furthering the=20 enthusiasm shared by leading neuroscientists at=20 the excellent Winterthur conference! Best regards -- Joe Siri Ekgren MD Oslo, Norway Ps. I am speaking on behalf of myself. Ds.